Search Within

Jaclyn Frances Hechtman

Formats
  1. Meeting Abstract (104)
  2. Journal Article (99)
  3. Review (4)
  4. Guidelines (2)
  5. Book Section (1)
  6. Correspondence (1)
  7. Research Letter (1)
Groups
  1. Department of Pathology and Laboratory Medicine (179)
  2. Department of Medicine (158)
  3. Solid Tumor Oncology Division (157)
  4. GSK Faculty (147)
  5. Human Oncology and Pathogenesis Program (133)
  6. Gastrointestinal Oncology Service (101)

More Groups

People
  1. Jinru Shia (85)
  2. Marc Ladanyi (69)
  3. Efsevia Vakiani (67)
  4. Michael Berger (66)
  5. David Klimstra (55)
  6. Ahmet Zehir (54)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (3)
  4. 2022 (6)
  5. 2021 (18)
  6. 2020 (23)

More Years

Publications
  1. Modern Pathology (37)
  2. Journal of Clinical Oncology (32)
  3. Laboratory Investigation (24)
  4. Clinical Cancer Research (15)
  5. Annals of Oncology (11)
  6. Journal of Molecular Diagnostics (11)

More Publications

Publishers
  1. American Society of Clinical Oncology (41)
  2. Nature Research (37)
  3. American Association for Cancer Research (33)
  4. Nature Publishing Group (31)
  5. Oxford University Press (15)
  6. Elsevier Science, Inc. (13)

More Publishers

Results (212)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Expression of PD-L1 in colorectal carcinoma (CRC) primarily occurs in stromal/immune cells at tumor-stroma interface (TSI), and is associated with high tumor-infiltrating lymphocytes (TILs) irrespective of the microsatellite instability (MSI) status or the molecular mechanism of MSI
    Meeting Abstract

    Liu, S.; Hechtman, J.; Segal, N.; Smith, J.; Rao, D.; Markowitz, A.; Weiser, M.; Vakiani, E.; Klimstra, D. S.; Stadler, Z.; more...
    Laboratory Investigation (2017)

    Fulltext@MSK | Save
  • Clinical and genetic determinants of ovarian metastases from colorectal cancer
    Journal Article

    Ganesh, K.; Shah, R. H.; Vakiani, E.; Nash, G. M.; Skottowe, H. P.; Yaeger, R.; Cercek, A.; Lincoln, A.; Tran, C.; Segal, N. H.; more...
    Cancer (2017)

    Fulltext@MSK | Save
  • MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation
    Journal Article

    Schaefer, I. M.; Wang, Y.; Liang, C. W.; Bahri, N.; Quattrone, A.; Doyle, L.; Marinõ-Enríquez, A.; Lauria, A.; Zhu, M.; Debiec-Rychter, M.; more...
    Nature Communications (2017)

    Fulltext@MSK | Save
  • Diagnosing colorectal medullary carcinoma: Interobserver variability and clinicopathological implications
    Journal Article

    Lee, L. H.; Yantiss, R. K.; Sadot, E.; Ren, B.; Calvacanti, M. S.; Hechtman, J. F.; Ivelja, S.; Huynh, B.; Xue, Y.; Shitilbans, T.; more...
    Human Pathology (2017)

    Fulltext@MSK | Save
  • Next-generation assessment of human growth factor receptor 2 (ERBB2) amplification status: Clinical validation in the context of a hybrid capture-based, comprehensive solid tumor genomic profiling assay
    Journal Article

    Ross, D. S.; Zehir, A.; Cheng, D. T.; Benayed, R.; Nafa, K.; Hechtman, J. F.; Janjigian, Y. Y.; Weigelt, B.; Razavi, P.; Hyman, D. M.; more...
    Journal of Molecular Diagnostics (2017)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) in advanced well differentiated pancreatic neuroendocrine tumors (WD pNETs): A study using MSK-IMPACT
    Meeting Abstract

    Raj, N. P.; Soumerai, T.; Valentino, E.; Hechtman, J. F.; Berger, M. F.; Reidy, D. L.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra- and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of prognostic features and potential targets for intervention
    Meeting Abstract

    Lowery, M. A.; Ptashkin, R.; Jordan, E.; Berger, M. F.; Zehir, A.; Kemeny, N. E.; O'Reilly, E. M.; Jarnagin, W. R.; Harding, J. J.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic profiling of pancreas ductal adenocarcinoma (PDA), actionability, and correlation with clinical phenotype
    Meeting Abstract

    Jordan, E.; Lowery, M. A.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Maynard, H.; Glassman, D. C.; Covington, C. M.; Schultz, N.; Abou-Alfa, G. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Emergence of RTK/RAS/PI3K pathway alterations in trastuzumab-refractory HER2-positive esophagogastric (EG) tumors
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Tuvy, Y.; Bouvier, N.; Riches, J. C.; Margolis, M.; Millang, B. M.; Scott, S. N.; Kundra, R.; Castel, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Somatic tumor profiling of DNA mismatch repair deficient (MMR-D) colorectal cancers (CRC)
    Meeting Abstract

    Ganesh, K.; Middha, S.; Hechtman, J. F.; Ashraf, A.; Tran, C.; Villano, D.; Yaeger, R. D.; Segal, N. H.; Cercek, A.; Varghese, A. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save